|
|
Start Date:12/5/2020
Start Time:2:00 PM EST
Duration:60 minutes
Abstract:
The event will feature members of the Kura management team along with two of the investigators from KOMET-001, an ongoing Phase 1/2A clinical trial of KO-539
If you're already registered for the Kura Oncology ASH Virtual Investor Event webcast, click below:
ALREADY REGISTERED?
Speakers
$-[WCSpeakerDisplayHTML]-$
|
|
Kura Oncology ASH Virtual Investor Event
Registration Is Closed
|
|
|
|
|